Belly tissue used to bypass brain barrier in cancer fight

NCT ID NCT04222309

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-stage trial tests a new surgical approach for recurrent glioblastoma, an aggressive brain cancer. After standard tumor removal, surgeons place a piece of abdominal tissue (omentum) into the brain cavity to bypass the blood-brain barrier. The study involves 10 adults and primarily checks for safety issues like infection, stroke, or rapid tumor growth over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
omental free flap (a piece of abdominal tissue transplanted into the brain)
What this could lead to
If successful, this could provide a new way to deliver treatments directly to brain tumors, potentially improving outcomes for recurrent glioblastoma.
What could go wrong
This is a very early phase 1 trial with only 10 participants, focused on safety. The procedure is invasive and carries risks like infection, stroke, or tumor progression. It may not improve survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lenox Hill Brain Tumor Center

    New York, New York, 10075, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.